Bayer sheds some brands to focus on pharma and fight pesticide claims
Share Now on:
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been growing since buying Monsanto earlier this year. Sounds good, but there’s a lingering problem that came with the Monsanto deal: Thousands of people have filed claims saying one of the company’s pesticides gave them cancer.
Click the audio player above to hear the full story.
As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.
Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.
Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.